Skip to main content
SENATE 331119th CongressReferred to the Committee on Foreign Relations. (text: CR S4531)

A resolution calling upon the Senate to give its advice and consent to the ratification of the United Nations Convention on the Law of the Sea.

Last Action
7/22/2025

Actions

  • 2025-07-16Became Public Law No: 119-26.
  • 2025-07-16Became Public Law No: 119-26.
  • 2025-07-16Signed by President.
  • 2025-07-16Signed by President.
  • 2025-07-08Presented to President.
  • 2025-07-08Presented to President.
  • 2025-06-12Motion to reconsider laid on the table Agreed to without objection.
  • 2025-06-12On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)
  • 2025-06-12Passed/agreed to in House: On passage Passed by the Yeas and Nays: 321 - 104 (Roll no. 166). (text: 6/11/2025 CR H2625-2627)
  • 2025-06-12Considered as unfinished business. (consideration: CR H2806)
  • 2025-06-11POSTPONED PROCEEDINGS - At the conclusion of debate on S. 331, the Chair put the question on passage of the bill and by voice vote, announced that the ayes had prevailed. Mr. Pallone demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
  • 2025-06-11The previous question was ordered pursuant to the rule.
  • 2025-06-11DEBATE - The House proceeded with one hour of debate on S. 331.
  • 2025-06-11Rule provides for consideration of H.R. 884, H.R. 2056, H.R. 2096 and S. 331. The resolution provides for consideration of H.R. 884, H.R. 2056, H.R. 2096, and S. 331 under a closed rule with one hour of general debate for each bill. The resolution provides for one motion to recommit on H.R. 884, H.R. 2056, and H.R. 2096, and one motion to commit on S. 331.
  • 2025-06-11Considered under the provisions of rule H. Res. 489. (consideration: CR H2625-2633)

Showing 15 of 20 actions. Full history on Congress.gov.

CRS Summary

As of 2025-07-17 (49)

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the act establishes a new, alternative registration process for certain schedule I research.

The act also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Cosponsors (20)

  • Martin Heinrich (D-NM)
  • Chuck Grassley (R-IA)
  • Roger Marshall (R-KS)
  • Todd Young (R-IN)
  • Steve Daines (R-MT)
  • Mike Rounds (R-SD)
  • Shelley Capito (R-WV)
  • Eric Schmitt (R-MO)
  • John Kennedy (R-LA)
  • Ruben Gallego (D-AZ)
  • Maggie Hassan (D-NH)
  • Catherine Cortez Masto (D-NV)
  • Jeanne Shaheen (D-NH)
  • Angus King (I-ME)
  • Mark Kelly (D-AZ)
  • John Cornyn (R-TX)
  • Josh Hawley (R-MO)
  • Thomas Tillis (R-NC)
  • Lindsey Graham (R-SC)
  • Ted Cruz (R-TX)

Subjects

  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances
  • Licensing and registrations
  • Research administration and funding

Became law: Pub. L. 119-26

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.